![]() |
|
|
Molecular Pharmacology, Vol 8, 362-370, Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics
-D-Arabinofuranosylcytosine
5'-Triphosphate and Mammalian Deoxyribonucleic
Acid Polymerase
1 McGill University Cancer Research Unit, Montreal, Quebec, Canada
Kinetic and template studies have been performed with 1-
-D-arabinofuranosylcytosine
5'-triphosphate (araCTP), dCTP, and calf thymus DNA polymerase. Using denatured
DNA as the template, the estimated apparent Km values for araCTP and dCTP were about
the same; however, the estimated apparent Vmax value for dCTP was about 8 times greater
than the apparent Vmax for araCTP. Both araCTP and dCTP appeared to complete for the
same catalytic site of DNA polymerase. When poly(dA-dT) was used as the template,
araCTP did not produce any detectable inhibition of the incorporation of [3H]dTTP into
acid-insoluble material. DNA Polymerase catalyzed the incorporation of [3H]araCTP into
poly dC:poly dG, but not into poly(dA-dT). DNA containing [
-32P]arabinofuranosylcytosine 5'-monophosphate ([
-32P]araCMP) was synthesized enzymatically, using denatured
DNA and DNA polymerase. Following the digestion of this [32P]DNA with micrococcal
nuclease and spleen phosphodiesterase to deoxynucleoside 3'-monophosphates, the radioactivity from [
-32P]araCMP appeared in 3'-dAMP, 3'-dGMP, 3'-dTMP, and 3'-dCMP,
suggesting that DNA polymerase could catalyze the formation of a phosphodiester bond
between araCMP and each of the deoxynucleotides present in the DNA template.
The data from studies on the rate of release of [
-32P]araCMP and [3H]dCMP from DNA
by snake venom phosphodiesterase and the incorporation of araCTP and dCTP into denatured, sonicated DNA are consistent with the proposal that the incorporation of araCTP
into DNA in the reaction catalyzed by DNA polymerase produces termination of polynucleotide chain growth.
Note:
ACKNOWLEDGMENT
I would like to thank Miss Aurora Labitan for
her excellent technical assistance in this work.